Tulsi Gabbard Resigns as Trumps Intelligence Chief to Care for Husband with Bone Cancer
SEBI Chief Tuhin Kanta Pandey Highlights Indias Diversified Market Amid Taiwans Ascent on TSMC and AI Boom
AnheuserBusch InBev Shares Dip as Sales Miss Market Expectations
JDcom Founder Pledges Job Protection for 900000 Workers Amid AIDriven Transformation
Meta to Test AI Subscription Services Starting at 799 Monthly
ByteDance Offers Special Stock Awards to AI Team to Counter Talent Poaching FT Reports
PJT Partners Q1 2026 Earnings EPS Misses Estimates Stock Declines
C4 Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline
NTIC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter
ASPN Q1 2026 Earnings EPS Misses Estimates as Losses Narrow but Surprise Negative
INTS Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Clinical Pipeline
Firefly Neuroscience AIFF Q3 1998 Earnings Heavy Loss Surprises Analysts Yet Stock Rises
Pulsenmore PLSM Surges 12 as Share Price Tests Key Resistance Level
Canaan Inc CAN Rises 38 as Bitcoin Mining Stock Approaches Resistance
60 Degrees Pharmaceuticals SXTP Holds Near Support After Minor Decline
Virco Manufacturing VIRC Edges Higher as Key Support Holds Near 574
Navitas Semiconductor NVTS Surges Over 8 on Strong Volume Testing Key Resistance
Entertainment Industry Amplifies Stronger Not Smaller Movement Hinting at Shifting Consumer Trends
APVO Q1 2026 Earnings Stock Rises Despite WiderThanExpected Loss as Pipeline Progress Takes Center Stage
ALAB Q1 2026 Earnings EPS Surges Past Estimates as AI Infrastructure Demand Drives Strong Performance
SpaceX OpenAI and Anthropic IPOs Could Trigger Wall Street Trading Frenzy as Passive Investors Rebalance
SNA Q1 2026 Earnings EPS Misses Estimates by a Narrow Margin Shares Edge Lower
AMD Commits Over 10 Billion to Taiwans AI and Semiconductor Ecosystem
Borosil Glass Works Shares Triple in One Year Amid Strong Revenue and EBIDTA Growth
HHH Q1 2026 Earnings Earnings Per Share Beat Estimates by 73 Stock Declines Slightly
Polaryx Therapeutics PLYX Slips 271 as Stock Tests Key Support Near 238